Loss of c-met protooncogene in primary and metastatic sites of breast cancer

Annals of Surgical Oncology

Volumn 4, Issue 6, 1997, Pages 499-502

  Ng, Eng Hen ^a   Pey, Huey Bee ^a   Law, Hai Yang ^a   Ng, Ivy ^a   Ji, Chen Yang ^a   Lin, Valerie ^a   Soo, Khee Chee ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Breast cancer metastases; c met protooncogene

Indexed keywords

DNA; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BREAST TUMOR; CARCINOMA; CHEMISTRY; DNA PROBE; FEMALE; GENETICS; HUMAN; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SOUTHERN BLOTTING; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BLOTTING, SOUTHERN; BREAST NEOPLASMS; CARCINOMA; COMBINED MODALITY THERAPY; DNA PROBES; DNA, NEOPLASM; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MET; RETROSPECTIVE STUDIES;

EID: 0031227707     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303675     Document Type: Article

References (19)

1. Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 1989;7:1239-51.
2. Fisher B, Redmond C, Fisher ER, et al. Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674-81.
3. Fidler IJ, Kripke ML. Metastasis results from pre-existing variant cells within a malignant tumor. Science 1977;197:893-5.
4. Hart IR, Saini. Biology of tumor metastasis. Lancet 1992;339:1453-7.
5. Steeg PS, Bevlaqua G, Kopper L, Thorgeirsson UP, Talmadge JE. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80:200-4.
6. Higuchi R. Perkin Elmer/Cetus Newletter Amplifications 1989, 2:1.
7. Park M, Gonzatti-Haces M, Dean M, et al. The Met oncogene; a new member of the tyrosine kinase family and a marker for cystic fibrosis. Cold Spring Harb Symp Quant Biol 1986;51:967-75.
8. Finklestein SD, Sayegh R, Christensen S, Swalsky PA. Genotypic classification of colorectal adenocarcinomas. Cancer 1993;71:3827-38.
9. Bergh J, Norberg T, Sjorgren S, Lindgren A, Holmberg L. Complete sequencing of the p53 gene provides prognostic information in the breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med 1995;1:1029-34.
10. Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R, Lidreau R. Loss of heterozygosity on chromosome 7 and aggressive breast cancer. Lancet 1992;339:139-143.
11. Devilee P, Van Vilet M, Van Sloun P, et al. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 1991;6:1705-11.
12. Cooke A, Kim YT, Harvey TI, Connor JM, Nagy J, George WD. Comment. Lancet 1993;341:1289.
13. Park M, Dean M, Kaul K, Braun MJ, Gonda M, Vande Woude G. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth factor receptors. Proc Natl Acad Sci U S A 1987;84:6379-83.
14. Chan M-LA, Rubin JS, Bottaro DP, Hirshfield DW, Chedid M, Aaronson SA. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science 1991;254:1382-5.
15. Weidner KM, Sachs M, Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelia cells. J Cell Biol 1993;121:145-54.
16. Suzuki K, Hayashi N, Yamada Y, et al. Expression of c-met protooncogene in human hepatocellular carcinoma. Hepatology 1994;20:1231-6.
17. Grigioni WF, Fiorentino M, D'Errico A, et al. Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinoma with respect to benign liver conditions. Hepatology 1995;21:1543-6.
18. Rahimi N, Saulnier R, Nakamura T, Park M, Elliot B, Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol 1994;13:1189-97.
19. Khine K, Smith DR, Goh HS. High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer. Cancer 1993;73:28-35.